Author

Minoru Sakamoto

Observed names: Minoru SAKAMOTO, SAKAMOTO, Minoru

Observed institutions: University of Yamanashi Hospital, University of Yamanashi

OpenAlex ID: A5110142927

Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection

2016 · Kazumoto Murata, Mai Asano, et al. · Gut · 201

PDF

Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features

2015 · Fukiko Kawai-Kitahata, Yasuhiro Asahina, et al. · Journal of Gastroenterology · 121

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

2018 · Tetsuo Takehara, Naoya Sakamoto, et al. · Journal of Gastroenterology · 120

PDF

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

2010 · Masayuki Kurosaki, Yasuhito Tanaka, et al. · Journal of Hepatology · 120

Higher prevalence and viral load of TT virus in saliva than in the corresponding serum: Another possible transmission route and replication site of TT virus

2000 · Xuewen Deng, Hiroshi Terunuma, et al. · Journal of Medical Virology · 82

Targeting Lipid Metabolism in the Treatment of Hepatitis C Virus Infection

2008 · Fumitake Amemiya, Shinya Maekawa, et al. · The Journal of Infectious Diseases · 65

Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma

2018 · Yuichiro Suzuki, Shinya Maekawa, et al. · Hepatology Research · 51

Hepatocellular carcinoma risk assessment using gadoxetic acid‐enhanced hepatocyte phase magnetic resonance imaging

2014 · Nobutoshi Komatsu, Utaroh Motosugi, et al. · Hepatology Research · 46

Liver stiffness measurement for risk assessment of hepatocellular carcinoma

2014 · Akihisa Tatsumi, Shinya Maekawa, et al. · Hepatology Research · 43

Deep-Sequencing Analysis of the Association between the Quasispecies Nature of the Hepatitis C Virus Core Region and Disease Progression

2013 · Mika Miura, Shinya Maekawa, et al. · Journal of Virology · 42

Deep sequencing analysis of variants resistant to the non‐structural 5 A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

2014 · Mika Miura, Shinya Maekawa, et al. · Hepatology Research · 38

Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis

2010 · Masayuki Kurosaki, Naoya Sakamoto, et al. · Journal of Gastroenterology · 37

Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C

2011 · Mika Miura, Shinya Maekawa, et al. · Hepatology International · 36

Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C

2011 · Masayuki Kurosaki, Naoki Hiramatsu, et al. · Journal of Hepatology · 33

Effect of interferon on a nonenveloped DNA virus (TT Virus) associated with acute and chronic hepatitis of unknown etiology

1999 · Yoshihiro Akahane, Minoru Sakamoto, et al. · Journal of Medical Virology · 31

Deep Sequencing and Phylogenetic Analysis of Variants Resistant to Interferon-Based Protease Inhibitor Therapy in Chronic Hepatitis Induced by Genotype 1b Hepatitis C Virus

2015 · Mitsuaki Sato, Shinya Maekawa, et al. · Journal of Virology · 30

Causes of Thrombocytopenia in Chronic Hepatitis C Viral Infection

2012 · Makoto Osada, Makoto Kaneko, et al. · Clinical and Applied Thrombosis/Hemostasis · 29

Elevation of the Hepatitis B Virus DNA during the Treatment of Polycythemia Vera with the JAK Kinase Inhibitor Ruxolitinib

2016 · Keita Kirito, Minoru Sakamoto, et al. · Internal Medicine · 25

PDF

Sequences in the interferon sensitivity‐determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG‐interferon plus ribavirin: Data mining analysis

2011 · Masayuki Kurosaki, Naoya Sakamoto, et al. · Journal of Medical Virology · 25

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection

2012 · Shinya Maekawa, Minoru Sakamoto, et al. · Hepatology · 21

PDF

Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

2011 · Naoki Hiramatsu, Masayuki Kurosaki, et al. · Journal of Gastroenterology · 21

Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients

2011 · Hiroko Shindo, Shinya Maekawa, et al. · Hepatology International · 20

Hepatic Amyloidosis with an Extremely High Stiffness Value on Magnetic Resonance Elastography

2016 · Shuya MATSUDA, Utaroh MOTOSUGI, et al. · Magnetic Resonance in Medical Sciences · 15

PDF

HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers

2019 · Yuichiro Suzuki, Shinya Maekawa, et al. · PLoS ONE · 13

PDF

Age and Total Ribavirin Dose are Independent Predictors of Relapse after Interferon Therapy in Chronic Hepatitis C Revealed by Data Mining Analysis

2011 · Masayuki Kurosaki, Naoki Hiramatsu, et al. · Antiviral Therapy · 11

Works count: 44

Citation count: 1,334

H-index: 21

I10-index: 28